Chongqing Genrix Biopharmaceutical Co., Ltd. (SHSE: 688443)
Health Care · Biotechnology · CN
CN¥24.95
-1.38% today · -14.6% 1Y
Chongqing Genrix Biopharmaceutical Co., Ltd. (SHSE: 688443) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.37B.
Over the last twelve months the share price has lost 14.6%, trading between 20.07 and 32.82.
Tweenvest scores Chongqing Genrix Biopharmaceutical Co., Ltd. across four factors: quality 40/100, value 64/100. Its strongest factor is value.
688443 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.37B
- Revenue (TTM)
- $49.82M
- P/E
- —
- EPS
- -1.53
- Dividend yield
- —
- Beta (5Y)
- 0.62
- 52-week high
- CN¥32.82
- 52-week low
- CN¥20.07
- Avg volume (3M)
- —
- Shares outstanding
- 366.68M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Inhibrx Biosciences, Inc.NasdaqGS: INBX | $1.40B | $95.01 | +2.43% |
| Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403 | $1.39B | CN¥9.96 | -0.99% |
| AnaptysBio, Inc.NasdaqGS: ANAB | $1.37B | $45.95 | -0.56% |
| Tyra Biosciences, Inc.NasdaqGS: TYRA | $1.37B | $19.94 | -2.40% |
| Idorsia LtdSWX: IDIA | $1.36B | CHF4.20 | -5.83% |
| GenFleet Therapeutics (Shanghai) Inc.SEHK: 2595 | $1.35B | HK$28.60 | -10.46% |
| Pharma Mar, S.A.BME: PHM | $1.35B | €69.45 | +1.24% |
| BeBetter Med Inc.SHSE: 688759 | $1.35B | CN¥20.05 | -7.56% |
Figures last refreshed Oct 11, 2026.